TEHRAN - The World Health Organization (WHO) has achieved a significant milestone by successfully facilitating the procurement of 2.79 million Vaccine Vial Monitors (VVMs) for the Islamic Republic of Iran’s oral polio vaccine program.

This strategic move that was funded by the Razi Vaccine and Serum Research Institute marks a substantial leap forward in strengthening the country’s national immunization efforts.

The shipment of VVMs, temperature-sensitive devices crucial for vaccine storage and transportation, arrived through Imam Khomeini International Airport.

The consignment was received jointly by the Razi Vaccine and Serum Research Institute and the WHO Country Office in the Islamic Republic of Iran. These VVMs were procured from a reputable international supplier.

Ali Es’haghi, Director General of the Razi Vaccine & Serum Research Institute affiliated with the Government of the Islamic Republic of Iran, indicated that the collaborative achievement was the result of concerted efforts across multiple levels.

He mentioned that the Razi Serum Vaccine Research Institute, the Ministry of Health and Medical Education, Iran Food and Drug Administration (IFDA), The Ministry of Industry, Mine and Trade, the WHO Country Office in the Islamic Republic of Iran, WHO Headquarters, and the Eastern Mediterranean Regional Office (EMRO) worked tirelessly for nearly two years to navigate a complex procurement process.